Market revenue in 2023 | USD 734.5 million |
Market revenue in 2030 | USD 2,142.7 million |
Growth rate | 16.5% (CAGR from 2023 to 2030) |
Largest segment | Tavr (transcatheter aortic valve replacement) |
Fastest growing segment | LAAC (Left Atrial Appendage Closure) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure) |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Edwards Lifesciences Corp, Abbott Laboratories, St. Jude Medical, LivaNova PLC, Stryker Corp, Lepu Medical, Biomerics, CardioKinetix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to structural heart devices market will help companies and investors design strategic landscapes.
Tavr (transcatheter aortic valve replacement) was the largest segment with a revenue share of 64.33% in 2023. Horizon Databook has segmented the Japan structural heart devices market based on savr (surgical aortic valve replacement), tavr (transcatheter aortic valve replacement), mitral repair (annuloplasty), laac (left atrial appendage closure) covering the revenue growth of each sub-segment from 2018 to 2030.
The burgeoning aging population and the escalating incidence of CVDs stand out as pivotal drivers propelling the structural heart devices market forward. With these health challenges on the rise, the demand for cutting-edge medical technologies becomes imperative for effective treatment.
Among the transformative advancements, TAVR and Transcatheter Mitral Valve Repair (TMVR) have emerged as game-changers, supplanting traditional open-heart surgical procedures. This shift toward minimally invasive interventions is buoyed by heightened patient awareness regarding therapeutic alternatives, fostering a steady surge in demand for these procedures.
Unlike many of its Asian counterparts, where the exorbitant costs of TAVR devices pose formidable barriers, Japan sets a striking example with its inclusive insurance coverage encompassing all treatment expenses, including those associated with TAVR procedures.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan structural heart devices market , including forecasts for subscribers. This country databook contains high-level insights into Japan structural heart devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account